Literature DB >> 31118160

Keratinocyte-derived TGFβ is not required to maintain skin immune homeostasis.

Yi Yang1, Yukari Zenke2, Toshiro Hirai3, Daniel H Kaplan4.   

Abstract

BACKGROUND: Transforming growth factor beta 1 (TGFβ) is known to be a regulator of autoimmunity. Loss of TGFβ leads to severe multi-organ autoimmunity in mice. In skin, role of TGFβ in suppressing autoimmunity is unclear.
OBJECTIVE: Determine whether Keratinocyte (KC)-derived TGFβ is required for skin immune homeostasis.
METHODS: We generated K14-CreERT2TGFβ1fl/fl (TGFβΔKC) mice allowing for tamoxifen-induced deletion of TGFβ1 in KC. The phenotype of skin was analyzed and compared to mice in which epidermal activation of TGFβ is impaired.
RESULTS: KC was the major source of TGFβ in epidermis. Topical tamoxifen application led to efficient TGFβ1 deletion. The expected acanthosis was observed but no inflammatory infiltrate or altered numbers of resident immune cells were evident. Similarly, Itgb6-/-x K14Cre Itgb8f/f (Itgb6-/-Itgb8ΔKC) mice lacking both epidermal TGFβ-activating integrins showed no evidence of cutaneous inflammation.
CONCLUSIONS: KC-derived TGFβ and epidermal TGFβ activation are not required to suppress skin autoimmunity in steady state.
Copyright © 2019 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Keratinocyte; Skin; TGFβ; α(v)β(6); α(v)β(8)

Mesh:

Substances:

Year:  2019        PMID: 31118160      PMCID: PMC6602918          DOI: 10.1016/j.jdermsci.2019.04.008

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  36 in total

1.  Control of murine hair follicle regression (catagen) by TGF-beta1 in vivo.

Authors:  K Foitzik; G Lindner; S Mueller-Roever; M Maurer; N Botchkareva; V Botchkarev; B Handjiski; M Metz; T Hibino; T Soma; G P Dotto; R Paus
Journal:  FASEB J       Date:  2000-04       Impact factor: 5.191

2.  Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity.

Authors:  Daniel H Kaplan; Mathew C Jenison; Sem Saeland; Warren D Shlomchik; Mark J Shlomchik
Journal:  Immunity       Date:  2005-12       Impact factor: 31.745

3.  The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis.

Authors:  J S Munger; X Huang; H Kawakatsu; M J Griffiths; S L Dalton; J Wu; J F Pittet; N Kaminski; C Garat; M A Matthay; D B Rifkin; D Sheppard
Journal:  Cell       Date:  1999-02-05       Impact factor: 41.582

4.  Latent TGFbeta1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder.

Authors:  Allen G Li; Donna Wang; Xin-Hua Feng; Xiao-Jing Wang
Journal:  EMBO J       Date:  2004-04-01       Impact factor: 11.598

5.  Expression of transforming growth factor type beta on human epidermal dendritic cells.

Authors:  M S Gruschwitz; O P Hornstein
Journal:  J Invest Dermatol       Date:  1992-07       Impact factor: 8.551

6.  Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease.

Authors:  M M Shull; I Ormsby; A B Kier; S Pawlowski; R J Diebold; M Yin; R Allen; C Sidman; G Proetzel; D Calvin
Journal:  Nature       Date:  1992-10-22       Impact factor: 49.962

Review 7.  Transforming growth factor-beta regulation of immune responses.

Authors:  Ming O Li; Yisong Y Wan; Shomyseh Sanjabi; Anna-Karin L Robertson; Richard A Flavell
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

8.  TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells.

Authors:  Julien C Marie; John J Letterio; Marc Gavin; Alexander Y Rudensky
Journal:  J Exp Med       Date:  2005-04-04       Impact factor: 14.307

9.  The integrin alpha(v)beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1.

Authors:  Dezhi Mu; Stephanie Cambier; Lars Fjellbirkeland; Jody L Baron; John S Munger; Hisaaki Kawakatsu; Dean Sheppard; V Courtney Broaddus; Stephen L Nishimura
Journal:  J Cell Biol       Date:  2002-04-22       Impact factor: 10.539

10.  Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis.

Authors:  Vissia Viglietta; Clare Baecher-Allan; Howard L Weiner; David A Hafler
Journal:  J Exp Med       Date:  2004-04-05       Impact factor: 14.307

View more
  5 in total

1.  Targeted deletion of TGFβ1 in basal keratinocytes causes profound defects in stratified squamous epithelia and aberrant melanocyte migration.

Authors:  Fiona E Chalmers; Justyn E Dusold; Javed A Shaik; Hailey A Walsh; Adam B Glick
Journal:  Dev Biol       Date:  2022-02-25       Impact factor: 3.582

2.  Competition for Active TGFβ Cytokine Allows for Selective Retention of Antigen-Specific Tissue- Resident Memory T Cells in the Epidermal Niche.

Authors:  Toshiro Hirai; Yi Yang; Yukari Zenke; Haiyue Li; Virendra K Chaudhri; Jacinto S De La Cruz Diaz; Paul Yifan Zhou; Breanna Anh-Thu Nguyen; Laurent Bartholin; Creg J Workman; David W Griggs; Dario A A Vignali; Harinder Singh; David Masopust; Daniel H Kaplan
Journal:  Immunity       Date:  2020-11-18       Impact factor: 31.745

Review 3.  TGF-β: Many Paths to CD103+ CD8 T Cell Residency.

Authors:  Zhijuan Qiu; Timothy H Chu; Brian S Sheridan
Journal:  Cells       Date:  2021-04-23       Impact factor: 6.600

4.  Keratinocytes Regulate the Threshold of Inflammation by Inhibiting T Cell Effector Functions.

Authors:  Peter Seiringer; Stefanie Eyerich; Kilian Eyerich; Daniela Dittlein; Anna Caroline Pilz; Emanuele Scala; Johannes Ring; Heidrun Behrendt; Andrea Cavani; Claudia Traidl-Hoffmann
Journal:  Cells       Date:  2021-06-26       Impact factor: 6.600

Review 5.  Regulation of barrier immunity and homeostasis by integrin-mediated transforming growth factor β activation.

Authors:  Craig P McEntee; Sezin Gunaltay; Mark A Travis
Journal:  Immunology       Date:  2019-12-25       Impact factor: 7.397

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.